Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc. financial statements

Axsome Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 638.5M10-K
Net income−USD 183.17M10-K
Cash and equivalentsUSD 322.93M10-Q
Total debtUSD 187.75M10-Q

Axsome Therapeutics, Inc. financials on 6ix · Axsome Therapeutics, Inc. on 6ix